Elevance Health Reports Second Quarter 2023 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Elevance Health Inc. (ELV) Tops Q2 EPS by 25c
July 19, 2023 6:01 AM EDTElevance Health Inc. (NYSE: ELV) reported Q2 EPS of $9.04, $0.25 better than the analyst estimate of $8.79. Revenue for the quarter came in at $43.4 billion versus the consensus estimate of $41.64 billion.
For earnings history and earnings-related data on Elevance Health Inc. (ELV) click here.
... More